Published in Stroke on January 14, 2016
A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med (2014) 18.12
Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med (2015) 12.70
Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med (2015) 12.06
Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol (2006) 10.51
Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med (2015) 9.58
Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol (2008) 9.02
Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med (2015) 6.96
The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke (2011) 3.03
CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke (2011) 2.52
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes. Stroke (2005) 2.12
Screening with MRI for Accurate and Rapid Stroke Treatment: SMART. Neurology (2015) 1.66
Hyperacute ischemic stroke: middle cerebral artery susceptibility sign at echo-planar gradient-echo MR imaging. Radiology (2004) 1.31
Middle cerebral artery (MCA) susceptibility sign at susceptibility-based perfusion MR imaging: clinical importance and comparison with hyperdense MCA sign at CT. Radiology (2000) 1.11
Thrombus imaging in acute stroke: correlation of thrombus length on susceptibility-weighted imaging with endovascular reperfusion success. Eur Radiol (2014) 1.01
Clinical and MRI predictors of no early recanalization within 1 hour after tissue-type plasminogen activator administration. Stroke (2011) 0.93
Distance to thrombus in acute middle cerebral artery occlusion: a predictor of outcome after intravenous thrombolysis for acute ischemic stroke. Stroke (2015) 0.91
T2* "susceptibility vessel sign" demonstrates clot location and length in acute ischemic stroke. PLoS One (2013) 0.90
Hyperdense middle cerebral artery sign in multidetector computed tomography: definition, occurrence, and reliability analysis. Neurol India (2009) 0.88
Length of occlusion predicts recanalization and outcome after intravenous thrombolysis in middle cerebral artery stroke. Stroke (2014) 0.87
Acute occlusion of the middle cerebral artery: early evaluation with triphasic helical CT--preliminary results. Radiology (1998) 0.84
Thrombus length estimation in acute ischemic stroke: a potential role for delayed contrast enhanced CT. J Neurointerv Surg (2013) 0.82
Morphology of susceptibility vessel sign predicts middle cerebral artery recanalization after intravenous thrombolysis. Stroke (2014) 0.81
Natural history of acute stroke due to occlusion of the middle cerebral artery and intracranial internal carotid artery. J Neuroimaging (2013) 0.78